Evaluation of some factors affecting the risk of kidney damage in patients with hypertension by Gharishvandi, Fatemeh et al.
 




Evaluation of some factors affecting the risk of kidney damage in patients with 
hypertension 
 
Fatemeh Gharishvandi¹, Faranak Kazerouni¹
,
*, Ali Rahimipour¹ , Malihe Nasiri
2 
 
1Department of Medical Laboratory Sciences, Faculty of Paramedical Sciences ,Shahid Beheshti University of Medical Sciences, 
Tehran ,Iran.  
2Department of Biostatics, Faculty of Paramedical Sciences,Tarbiat Modares University, Tehran ,Iran. 
 




     Chronic kidney disease (CKD) is an increasing cause of morbidity and mortality worldwide. Prospective 
data on risk factors for CKD are few. Hypertension is one of the risk factors for CKD. In the past serum 
creatinine concentration was used as marker of kidney function but it proffers a late reflection of reduced 
glomerular filtration rate(GFR), which limits its ability to detect impaired kidney function. Cystatin C and 
NGAL have recently been proven useful to quantitate CKD. Therefore in this study, we assessed the effect of 
some risk factors on reduction of estimated glomerular filtration rate (eGFR) in patients with high blood 
pressure. This study was performed on 42 hypertensive patients and 30 healthy volunteers, both with normal 
serum creatinine and urea concentration. In this study, we measured serum cystatin C and Plasma NGAL. 
Serum creatinine and urea levels of the patients were measured after an overnight fasting.  . Estimated 
glomerular filtration rate (eGFR) was considered as the gold standard method .Serum cystatin C and plasma 
NGAL were measured using commercially available human ELISA kits. Logistic   regression and T-test were 
used for statistical analysis. The results of logistic regression showed that among the variables studied, plasma 
levels of NGAL, age and duration of hypertension were significantly associated with the eGFR<78(P<0.05). 
Our findings suggest that, increased levels of NGAL, age and duration of hypertension predicts a higher odds 
of impaired renal function. 
 




     Chronic kidney disease (CKD) is increasingly 
recognized as a global public health problem .CKD 
is renal injury or decreased kidney function 
(eGFR) for at least 3 months months, as defined by 
structural or functional abnormalities of  kidney, 
with or without decreased glomerular filtration rate 
(GFR).  Incidence and prevalence of CKD are 
increasing  rapidly, having doubled in past  decade 
due to enhanced longevity of patients with chronic 
diseases [1, 2]. Extensive studies indicate that  
chronic kidney disease is a risk factor for other  
diseases such as: cardiovascular disease [3, 4], 
anemia [5], electrolyte abnormalities [6], bone 
disease [7] and  cognitive and mental disorders[8]. 
In the meta-analysis conducted in 2008, it was 
estimated that the prevalence of chronic kidney 
disease in persons older than 30 years was about 
2.7%  and in persons older than 65 years was about 
35% [9]. Hypertension is considered to be one of 
the risk factors of chronic renal failure. Kidneys 
are the most sensitive organs in the human body 
that are affected by high blood pressure [10], one 
complication that affects the kidneys is chronic 
kidney disease; Hence, early identification of those 
likely to progress to end-stage renal disease 
(ESRD) has become important [11]. Serum 
creatinine (Scr) as a marker of kidney function has 
already been used, it has been shown that Scr is 
influenced by factors such as muscle mass, gender 
and race and eGFRs are less reliable for assessing 
renal function when GFR is more than 60ml/min. 
An early marker of kidney damage would promote 
earlier intervention in order to arrest the 
progression to end-stage renal disease (ESRD). In 
order to be of use to the general clinician, the 
 




biomarker must indicate renal damage prior to the 
current indicators of kidney function , it should be 
available, non-invasive and  easily interpretable 
[12-14]. Several studies are currently being 
conducted in this regard with the hope that early 
identification of kidney disease will lead to early 
treatment. One example of promising kidney 
biomarkers is cystatin C [11, 15]. Another potential 
biomarkers is neutrophil gelatinase-associated 
lipocalin (NGAL) which is a small, robust protein 
expressed by neutrophils and various epithelia, 
including the renal proximal tubules. While 
initially proposed as a marker for infections and 
certain adenocarcinomas, it is now apparent that its 
early and dramatic rise in urine after renal injury 
may make it a useful marker of such injury [16]. 
Other risk factors such as age, sex [17, 18] and 
systolic blood pressure [19] are also noted. 
 
MATERIALS AND METHODS 
     Forty two hypertensive patients who referred to 
Shohada Tajrish hospital were studied: 10 males 
and 32 females, mean age was 54.33±8.9 years. 
We considered subjects to have hypertension if 
their 24h blood pressure (BP) was ≥ 140  mmHg 
systolic or ≥90 mmHg diastolic. Exclusion criteria 
included underlying diseases such as diabetes, liver 
disease, cardiovascular disease , elevated serum 
creatinine and urea. Normal control blood samples 
were collected from 30 healthy subjects with mean 
age 54.7±6.8 without serological abnormality. 
Control group consisted of 14 males and 16 
females. Fasting blood samples were collected 
from participants; serum and plasma were 
separated and frozen until assay. For NGAL 
measurement blood was placed into chilled 
vacutainer tubes containing potassium 
ethylenediamine tetracetate (EDTA) . The plasma 
was promptly separated by a refrigerated 
centrifuge (at 4c,5min,5000rpm)[20, 21]. The 
samples were stored at -20 c until assessment time.. 
Plasma NGAL and Scys were measured using an 
enzyme-linked immunosorbent assay (ELISA) 
method (Biovender,Norway). Biochemical 
parameters including urea, creatinines were 
measured according to the standard methods in the 
routine clinical laboratory. GFR was estimated 
from Scr using the  Cockcroft and Gault formula 
[22] and all clearances were expressed as 
ml/min/1.73m
2
 after correction for body surface 
area (BSA) according to the DuBois-DuBois 
formula [23]. 
Statistical analysis 
     Results are expressed as mean± standard 
deviation. P values lower than 0.05 were 
considered as significant. For comparisons 
between groups, student’s ―t‖ test was used for 
continuous variables. Logistic regression model 
was used to adjust the correlations between chronic 
risk factors for chronic kidney disease in our study 
and eGFR. Analysis was developed with the 
statistical package SPSS 18. 
 
RESULTS 
Based on the results obtained, as shown in table 1, 
the pNGAL, Scys levels, diastolic BP, systolic BP 
and eGFRs were significantly higher in the patients 




Table1. Comparison of the mean pNGAL, Scys , Scr, eGFR, systolic BP, diastolic BP and urea in the patient and the control group. 
P-Value Patient Group Control Group Variables 
 n=42 n=30  
<0.001 124.54±118.67 14.59±3.71 pNGAL(ng/ml) 
<0.05 1120.9±229.1 829.27±295.65 Scys (ng/ml) 
0.001 77.73±20.19 90.74±10.38 eGFR(ml/min/1.73m²) 
<0.01 160.5±18mmHg 110.5±10.5 Systolic BP 
























In this study to determine the relationship between 
variables such as age, sex, Scys , pNGAL and 
systolic BP and reduction of renal function, logistic 
regression was used. Using eGFR <78 as 
dependent variable in a multiple regression model 
including all previously reported in analysis, only 
the  association of dependent variable with 
pNGAL, age, duration of disease  remained 
significant(p<0.05). Table 2 provides a resume of 
these reports. The odds of incident of renal damage 
in hypertensive patients was increased by 28%, for 
each one year increase in duration of disease, the 
odds of incident of  renal damage  increased 32% 
for each one year increase of age. The odds of 
incident of renal damage was 2.6 times greater for 




     Since hypertension is one of the most popular 
and the  most common risk factor of chronic 
kidney disease [24]in this study, patients with 
hypertension were selected. In order to 
determine the odds of reduced renal function in 
hypertensive patient, pNGAL, Scys and Scr 
concentrations, age, sex and duration of disease 
were determined. NGAL early and marked 
response to the injury (within 2 hours)[25] 
makes it one of the best markers which up to 
now, studied. Raised NGAL of renal origin is a 
direct response to tubule cell injury, while the 
others are functional markers that may, after a 
period of time, reveal the effect of such an injury 
on the accumulation of creatinine and cystatin C in 
the blood [26]. Cystatin c is produced by all 
nucleated cells but origin of serum NGAL remains 
debatable. In this study, we hypothesized NGAL is 
produced  mainly by damaged tubular cells in 
direct proportion to the degree and severity of the 
disease [27, 28].  
In our study by exclusion of patients with 
underlying diseases such as diabetes, liver and 
cardiovascular disease interfering factors, such as 
activated neutrophils and vascular inflammation 
were omitted; perhaps this is strength of our study 
in comparison with other studies. The results of 
logistic regression to determine the risk of kidney 
damage indicated that pNGAL was an independent 
predictor of an unfavorable clinical course and 
markedly improved the performance of the 
prediction model, this result is consistent with the 
observation of  David Bolignano et al [20]who 
reported a significant correlation for NGAL 
concentrations and age on the risk of kidney injury  
progression in regression analysis and a strict, 
independent and inverse correlation of NGAL with 
estimated GFR, suggesting that under these 
particular conditions this protein may also 
represent a surrogate index of residual renal 
function. Our results are in accordance with  results 
obtained by Colins et al [17] who showed 
significant correlation between age and duration of 
disease as  the most important risk factor for the 
loss of renal function. Increased levels of NGAL 
also predicted higher odds of renal function 
decrease.  
In our study, the systolic BP was not significantly 
associated with decreased eGFR. In contrast to our 
study Haroun et al [29]found a significant 
relationship between gender and decreased renal 
function inconsistency of our results with the 
above 2 studies could probably be due  to the small 
size of our study population. Based on our results 
from multiple regression analysis cystatin C was 
not as an independent marker associated with 
eGFR; similarly Mena et al [30] found that cystatin 
C concentration in hypertensive patients  was not  
correlated with GFR, probably because cystatin C 
has cardiovascular effects beyond its use as a 
marker of the renal function. In summary, we 
P-value 95%CI Odds ratio(OR)  Variables 
0.37 0.41-1.38 0.76 Systolic BP 
0.02 1.03-1.59 1.28 Duration of disease(year) 
0.009 1.07-1.63 1.32 Age(year) 
0.085 0.73_122.27 9.475 Sex 
0.028 1.01-1.2 2.6 pNGAL(ng/ml) 
0.5 0.99-1 1 Scys (ng/ml) 
 




found that pNGAL levels, duration of the 
hypertension and age clearly correlate with severity 
of renal impairment, probably expressing the 
degree of active damage underlying the chronic 
condition. However, our results should be 




     Our study suggests that NGAL, duration of the 
hypertension and age may help in stratifying odds 
of renal dysfunction in patients with hypertension. 
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